SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-024076
Filing Date
2021-05-05
Accepted
2021-05-05 16:16:06
Documents
14
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-8k_20210505.htm   iXBRL 8-K 40120
2 EX-99.1 adpt-ex991_6.htm EX-99.1 286802
3 GRAPHIC gh4igjlflklp000001.jpg GRAPHIC 7887
  Complete submission text file 0001564590-21-024076.txt   483098

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adpt-20210505.xsd EX-101.SCH 5804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20210505_lab.xml EX-101.LAB 19480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20210505_pre.xml EX-101.PRE 11653
7 EXTRACTED XBRL INSTANCE DOCUMENT adpt-8k_20210505_htm.xml XML 3575
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 21893481
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences